{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:46:01Z","timestamp":1777128361901,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Jiangxi Provincial Graduate Innovation Special Fund","award":["No. YC2024-B083"],"award-info":[{"award-number":["No. YC2024-B083"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82360460"],"award-info":[{"award-number":["No. 82360460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28798-6","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T13:04:08Z","timestamp":1763903048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TESMIN promotes lung adenocarcinoma proliferation, migration and invasion via PI3K\/AKT\/mTOR signaling"],"prefix":"10.1038","volume":"15","author":[{"given":"Chengpeng","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shansong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sili","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"28798_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"28798_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"28798_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446\u2013454 (2018).","journal-title":"Nature"},{"key":"28798_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac. Cancer 11, 511\u2013518 (2020).","journal-title":"Thorac. Cancer"},{"key":"28798_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101364","volume":"18","author":"MJ Sanaei","year":"2022","unstructured":"Sanaei, M. J., Razi, S., Pourbagheri-Sigaroodi, A. & Bashash, D. The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. Transl. Oncol. 18, 101364 (2022).","journal-title":"Transl. Oncol."},{"key":"28798_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman, J. A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9, 550\u2013562 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"28798_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011189","volume":"4","author":"BA Hemmings","year":"2012","unstructured":"Hemmings, B. A. & Restuccia, D. F. PI3K-PKB\/Akt pathway. Cold Spring Harb. Perspect. Biol. 4, a011189 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"28798_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman, D. A. et al. The PI3K pathway in human disease. Cell 170, 605\u2013635 (2017).","journal-title":"Cell"},{"key":"28798_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","volume":"16","author":"D Morgensztern","year":"2005","unstructured":"Morgensztern, D. & McLeod, H. L. PI3K\/Akt\/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16, 797\u2013803 (2005).","journal-title":"Anticancer Drugs"},{"issue":"1078","key":"28798_CR10","first-page":"1089","volume":"169","author":"Z Feng","year":"2017","unstructured":"Feng, Z. et al. Structural basis for mitotic centrosome assembly in flies. Cell 169(1078), 1089 (2017).","journal-title":"Cell"},{"key":"28798_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55\u201361 (2012).","journal-title":"Nature"},{"key":"28798_CR12","doi-asserted-by":"publisher","first-page":"a012336","DOI":"10.1101\/cshperspect.a012336","volume":"5","author":"D Ruggero","year":"2013","unstructured":"Ruggero, D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 5, a012336 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"28798_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122\u20131128 (2004).","journal-title":"Nat. Cell Biol."},{"key":"28798_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307, 1098\u20131101 (2005).","journal-title":"Science"},{"key":"28798_CR15","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","volume":"10","author":"WJ Oh","year":"2011","unstructured":"Oh, W. J. & Jacinto, E. mTOR complex 2 signaling and functions. Cell Cycle 10, 2305\u20132316 (2011).","journal-title":"Cell Cycle"},{"key":"28798_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ceb.2015.08.005","volume":"36","author":"AJ Ridley","year":"2015","unstructured":"Ridley, A. J. Rho GTPase signalling in cell migration. Curr. Opin. Cell Biol. 36, 103\u2013112 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"28798_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","volume":"144","author":"V Zinzalla","year":"2011","unstructured":"Zinzalla, V., Stracka, D., Oppliger, W. & Hall, M. N. Activation of mTORC2 by association with the ribosome. Cell 144, 757\u2013768 (2011).","journal-title":"Cell"},{"key":"28798_CR18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou, B. P. et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931\u2013940 (2004).","journal-title":"Nat. Cell Biol."},{"key":"28798_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056664","volume":"8","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. Epithelial-mesenchymal transition (EMT) induced by TNF-alpha requires AKT\/GSK-3beta-mediated stabilization of snail in colorectal cancer. PLoS One 8, e56664 (2013).","journal-title":"PLoS One"},{"key":"28798_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"28798_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"28798_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128\u2013134 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"28798_CR23","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1158\/1078-0432.CCR-14-3281","volume":"21","author":"PN Lara Jr","year":"2015","unstructured":"Lara, P. N. Jr. et al. Phase II study of the AKT inhibitor MK-2206 plus erlotinib in patients with advanced non-small cell lung cancer who previously progressed on erlotinib. Clin. Cancer Res. 21, 4321\u20134326 (2015).","journal-title":"Clin. Cancer Res."},{"key":"28798_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10637-016-0382-3","volume":"35","author":"N Yamamoto","year":"2017","unstructured":"Yamamoto, N. et al. Phase Ia\/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancer. Invest. New Drugs 35, 37\u201346 (2017).","journal-title":"Invest. New Drugs"},{"key":"28798_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway?. Nat. Rev. Clin. Oncol. 15, 273\u2013291 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"28798_CR26","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.3390\/molecules26134100","volume":"26","author":"S Iksen","year":"2021","unstructured":"Iksen, S. & Pothongsrisit, V. Pongrakhananon, targeting the PI3K\/AKT\/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products. Molecules 26, 4100 (2021).","journal-title":"Molecules"},{"key":"28798_CR27","first-page":"1517","volume":"14","author":"N Coleman","year":"2021","unstructured":"Coleman, N., Moyers, J. T., Harbery, A., Vivanco, I. & Yap, T. A. Clinical development of AKT inhibitors and associated predictive biomarkers to guide patient treatment in cancer medicine. Pharmgenomics Pers. Med. 14, 1517\u20131535 (2021).","journal-title":"Pharmgenomics Pers. Med."},{"key":"28798_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/biolre\/ioaa002","volume":"102","author":"A Oji","year":"2020","unstructured":"Oji, A. et al. Tesmin, Metallothionein-Like 5, is required for spermatogenesis in micedagger. Biol. Reprod. 102, 975\u2013983 (2020).","journal-title":"Biol. Reprod."},{"key":"28798_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0162-0134(01)00377-4","volume":"88","author":"T Matsuura","year":"2002","unstructured":"Matsuura, T. et al. Germ cell-specific nucleocytoplasmic shuttling protein, tesmin, responsive to heavy metal stress in mouse testes. J. Inorg. Biochem. 88, 183\u2013191 (2002).","journal-title":"J. Inorg. Biochem."},{"key":"28798_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009753","volume":"17","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Nuclear translocation of MTL5 from cytoplasm requires its direct interaction with LIN9 and is essential for male meiosis and fertility. PLoS Genet. 17, e1009753 (2021).","journal-title":"PLoS Genet."},{"key":"28798_CR31","first-page":"253","volume":"42","author":"J Grzegrzolka","year":"2019","unstructured":"Grzegrzolka, J. et al. Expression of tesmin (MTL5) in non-small cell lung cancer: a preliminary study. Oncol. Rep. 42, 253\u2013262 (2019).","journal-title":"Oncol. Rep."},{"key":"28798_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3892\/ol.2020.12309","volume":"21","author":"J Grzegrzolka","year":"2021","unstructured":"Grzegrzolka, J. et al. Role of tesmin expression in non-small cell lung cancer. Oncol. Lett. 21, 48 (2021).","journal-title":"Oncol. Lett."},{"key":"28798_CR33","doi-asserted-by":"publisher","first-page":"3058875","DOI":"10.1155\/2024\/3058875","volume":"2024","author":"L Cao","year":"2024","unstructured":"Cao, L., Zhang, L., Liu, S. & Wang, X. Clinical significance and functional insights of tesmin in hepatocellular carcinoma. Genet. Res. (Camb) 2024, 3058875 (2024).","journal-title":"Genet. Res. (Camb)"},{"key":"28798_CR34","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1080\/21655979.2022.2036901","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Wu, Q. & Tan, X. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma. Bioengineered 13, 6955\u20136965 (2022).","journal-title":"Bioengineered"},{"key":"28798_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"28798_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nn.3351","volume":"16","author":"W Huang","year":"2013","unstructured":"Huang, W. et al. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 16, 441\u2013448 (2013).","journal-title":"Nat. Neurosci."},{"key":"28798_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB Signaling: Navigating the Network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"28798_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"28798_CR39","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/21\/27\/274001","volume":"21","author":"JC Budich","year":"2010","unstructured":"Budich, J. C. & Trauzettel, B. Entanglement transfer from electrons to photons in quantum dots: an open quantum system approach. Nanotechnology 21, 274001 (2010).","journal-title":"Nanotechnology"},{"key":"28798_CR40","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI44145","volume":"121","author":"SA Wander","year":"2011","unstructured":"Wander, S. A., Hennessy, B. T. & Slingerland, J. M. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J. Clin. Invest. 121, 1231\u20131241 (2011).","journal-title":"J. Clin. Invest."},{"key":"28798_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","volume":"13","author":"B Vanhaesebroeck","year":"2012","unstructured":"Vanhaesebroeck, B., Stephens, L. & Hawkins, P. PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol. 13, 195\u2013203 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"28798_CR42","doi-asserted-by":"crossref","unstructured":"M. Holgado-Madruga, D. K. Moscatello, D. R. Emlet, R. Dieterich, A. J. Wong, Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci U S A 94, 12419-12424 (1997).","DOI":"10.1073\/pnas.94.23.12419"},{"key":"28798_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1242\/jcs.037226","volume":"122","author":"R Eulenfeld","year":"2009","unstructured":"Eulenfeld, R. & Schaper, F. A new mechanism for the regulation of Gab1 recruitment to the plasma membrane. J. Cell Sci. 122, 55\u201364 (2009).","journal-title":"J. Cell Sci."},{"key":"28798_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub, N. & Baker, S. J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4, 127\u2013150 (2009).","journal-title":"Annu. Rev. Pathol."},{"key":"28798_CR45","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgescu","year":"2010","unstructured":"Georgescu, M. M. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes. Cancer 1, 1170\u20131177 (2010).","journal-title":"Genes. Cancer"},{"key":"28798_CR46","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev-pharmtox-031820-122108","volume":"61","author":"TR Baffi","year":"2021","unstructured":"Baffi, T. R., Cohen-Katsenelson, K. & Newton, A. C. PHLPPing the Script: emerging roles of PHLPP phosphatases in cell signaling. Annu. Rev. Pharmacol. Toxicol. 61, 723\u2013743 (2021).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"28798_CR47","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O Soderberg","year":"2006","unstructured":"Soderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995\u20131000 (2006).","journal-title":"Nat. Methods"},{"key":"28798_CR48","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/s41598-018-23582-1","volume":"8","author":"A Klaesson","year":"2018","unstructured":"Klaesson, A. et al. Improved efficiency of in situ protein analysis by proximity ligation using UnFold probes. Sci. Rep. 8, 5400 (2018).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28798-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:03:50Z","timestamp":1777125830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28798-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (Approval No. (2023)CDYFYYLK(11-018)) and conducted under the framework of the Tumor Genome Mapping Project (approved on May 1, 2022). All procedures were performed in accordance with institutional and national regulations for the care and use of laboratory animals.Prior to subcutaneous injection, mice were anesthetized with isoflurane to minimize pain and distress. At the end of the experiment, euthanasia was performed using carbon dioxide (CO\n                      2\n                      ) inhalation in accordance with internationally accepted guidelines for the humane treatment of laboratory animals.This study adhered strictly to the 3Rs principle (Replacement, Reduction, and Refinement) to minimize animal usage and suffering.All procedures involving animals were performed in strict accordance with institutional, national, and internationally accepted standards for the ethical treatment of experimental animals.This study is reported in accordance with the ARRIVE (Animal Research: Reporting of In vivo Experiments) guidelines (\n                      \n                      ) to ensure rigorous and transparent reporting of animal research.Written informed consent was obtained from all participants involved in the human studies. All procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication of the data and any accompanying images was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"45177"}}